Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience
A Anzuini,
S Rosanio,
V Legrand,
M Tocchi,
R Coppi,
H Bonnier,
I Sheiban,
HE Kulbertus,
and
SL Chierchia
Department of Cardiology, San Raffaele Hospital, Milan, Italy.
OBJECTIVES: This study reports the first multicenter experience with the Wiktor coil stent for treatment of chronic total coronary artery occlusions (CTOs). BACKGROUND: Percutaneous transluminal coronary angioplasty (PTCA) of CTO is associated with very high restenosis and reocclusion rates. Coronary stenting has been proposed as a means of improving outcome. However, the Wiktor device for CTOs has never been tested in a large patient sample. METHODS: From January 1993 to December 1996, 89 patients with 91 CTOs underwent Wiktor stent implantation after successful PTCA. The post-stenting regimen consisted of warfarin (Coumadin) plus aspirin in the initial 49 patients (55%) and aspirin plus ticlopidine in 40 patients (45%). RESULTS: Stenting was successful in 87 patients (98%). At 1 month, 6% of patients had subacute stent thrombosis, 3% had a major bleeding event, and 1% had access-site complications. Subacute stent thrombosis showed univariate association with warfarin therapy (p = 0.009). Angiographic follow-up was obtained in 76 (93%) of 82 eligible patients. The restenosis rate was 32%, including 4% reocclusions. By multiple logistic regression analysis, restenosis was independently associated with multiple stents (adjusted odds ratio [OR] 27.67, 95% confidence interval [CI] 4.25 to 79.95, p = 0.0008) and increasing values of occlusion length (adjusted OR 1.23, 95% CI 1.09 to 1.39, p = 0.001). Freedom from death, myocardial infarction or stented vessel revascularization was 87% and 72% at 1 and 3 years, respectively. CONCLUSIONS: Short- and long-term clinical and angiographic outcomes are favorable in patients undergoing Wiktor stent implantation in CTO. Further technical improvement is needed to reduce the restenosis rate in patients with long lesions and multiple stents.
This article has been cited by other articles:

|
 |

|
 |
 
G. Di Giammarco, M. Pano, M. Giancane, A. Di Francesco, and M. Di Mauro
Off-Pump Revascularization of Chronically Occluded Left Anterior Descending Artery Through Left Anterior Small Thoracotomy: Early and Late Angiographic and Clinical Follow-Up.
Ann. Thorac. Surg.,
October 1, 2006;
82(4):
1446 - 1450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sakakibara, S. Goto, K. Eto, N. Tamura, T. Isshiki, and S. Handa
Application of Ex Vivo Flow Chamber System for Assessment of Stent Thrombosis
Arterioscler Thromb Vasc Biol,
August 1, 2002;
22(8):
1360 - 1364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gruberg, R. Mehran, G. Dangas, M. K. Hong, G. S. Mintz, R. Kornowski, A. J. Lansky, K. M. Kent, A. D. Pichard, L. F. Satler, et al.
Effect of plaque debulking and stenting on short- and long-term outcomes after revascularization of chronic total occlusions
J. Am. Coll. Cardiol.,
January 1, 2000;
35(1):
151 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|